{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2021/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Thomas Victor Magee", "item": "https://www.patentleaderboard.com/2021/inventor/fl:th_ln:magee-3"}]}

Home › 2021 › Pfizer › Thomas Victor Magee

Thomas Victor Magee — 1 Patent in 2021

Pfizer: 1 patents #97 of 325Top 30%

Winchester, MA: #59 of 138 inventorsTop 45%

Massachusetts: #4,998 of 14,123 inventorsTop 40%

Overall (2021): #234,810 of 548,734Top 45%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
10988463	Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors	Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Brian Raymer +5 more	2021-04-27	$1,331,995,000

Thomas Victor Magee — 1 Patent in 2021

Issued Patents 2021

Patent Widget